FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to pharmaceutics and medicine, and concerns a drug preparation for preventing or treating androgen independent prostate cancer containing (+)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-2-naphthamide or a salt thereof.
EFFECT: drug preparation shows high efficacy.
4 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FLUORINATED DERIVATIVES OF 4-AZASTEROID AS ANDROGEN RECEPTOR MODULATORS | 2003 |
|
RU2320670C2 |
| TRICYCLIC COMPOUND AND ITS PHARMACEUTICAL APPLICATION | 2007 |
|
RU2456278C2 |
| IMPURITIES | 2019 |
|
RU2800278C2 |
| IMIDAZODIAZEPINE COMPOUND | 2016 |
|
RU2712968C2 |
| AGENT WHICH PREVENTS PREMATURE OVULATION | 2006 |
|
RU2419435C2 |
| THIENOPYRIMIDINE COMPOUNDS AND THEIR APPLICATION | 2004 |
|
RU2331648C2 |
| IMIDAZODIAZEPINE COMPOUND | 2016 |
|
RU2777915C2 |
| SELECTIVE ANTAGONISTS OF EP4 RECEPTOR FOR CANCER TREATMENT | 2010 |
|
RU2563817C2 |
| SUBSTITUTED 1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONES | 2019 |
|
RU2812726C2 |
| NEW ISOINDOLE DERIVATIVES, COMPOSITIONS CONTAINING THEREOF, PRODUCTION AND PHARMACEUTICAL APPLICATION THEREOF, PARTICULARLY AS INHIBITORS OF CHAPERONE PROTEIN Hsp90 ACTIVITY | 2006 |
|
RU2375361C2 |
